Fundamentals Overview
Centene Corporation is in the middle of its 52-week range with low valuation, trading relatively flat today.
Valuation low
Intrinsic value (DCF)
+534.4% upside vs price
Risk (Beta)
0.59 — lower vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +534.4% upside vs price
Pressures (Sell):
3M vs S&P 500: -19.6% · 3M vs Healthcare sector: -12.8%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: C+. Recent institutional grades: mixed. Current institutional positions: Buy: 3, Equal Weight: 10, Hold: 1, Neutral: 11, Outperform: 3, Overweight: 1, Sell: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $238.37; current price is $37.58. That’s a +534.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| DCF value (model) | $238.37 (534.4% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 0.92 |
| P/S (TTM) | 0.09 |
| P/FCF (TTM) | 4.28 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.68 |
| Quick Ratio (TTM) | 1.68 |
| Cash Ratio (TTM) | 0.83 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -3.43% |
| Gross margin (TTM) | 12.24% |
| Operating margin (TTM) | -3.91% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for CNC.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| JP Morgan | maintain | Neutral | Neutral | 2026-03-19 |
| Mizuho | maintain | Neutral | Neutral | 2026-03-11 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-03-04 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-18 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2026-02-09 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-01-07 |
| Barclays | upgrade | Equal Weight | Overweight | 2026-01-05 |
| Bernstein | maintain | Outperform | Outperform | 2025-11-21 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-11-12 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-11-04 |
| JP Morgan | maintain | Neutral | Neutral | 2025-11-04 |
| Goldman Sachs | maintain | Sell | Sell | 2025-10-31 |
| TD Cowen | maintain | Hold | Hold | 2025-10-31 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2025-10-30 |
| Truist Securities | maintain | Buy | Buy | 2025-10-30 |
| UBS | maintain | Neutral | Neutral | 2025-10-30 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-10-14 |
| Mizuho | maintain | Neutral | Neutral | 2025-10-09 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-10-07 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-09-12 |
| Truist Securities | maintain | Buy | Buy | 2025-09-12 |
| Bernstein | maintain | Outperform | Outperform | 2025-09-05 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-09-04 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2025-08-26 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-08-04 |
| JP Morgan | maintain | Neutral | Neutral | 2025-07-29 |
| Truist Securities | maintain | Buy | Buy | 2025-07-28 |
| UBS | maintain | Neutral | Neutral | 2025-07-28 |
| Cantor Fitzgerald | downgrade | Overweight | Neutral | 2025-07-28 |
| Oppenheimer | maintain | Outperform | Outperform | 2025-07-28 |